Market Research Logo

Serbia Pharmaceuticals & Healthcare Q4 2018

Serbia Pharmaceuticals & Healthcare Q4 2018

Key View:

The Serbian pharmaceutical market will continue to grow moderately over our forecast period, driven by an agingpopulation, high a high non-communicable disease burden and a growing government commitment to improve the healthcaresystem. However, the market will continue to be dominated by lower-value generic medicines, with opportunities for innovativedrugmakers limited by Serbia’s weak regulatory environment and low purchasing power.


Key View
SWOT
Industry Forecast
Pharmaceuticals Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Overview
Market Overview
Competitive Landscape
Company Profile
Galenika
Hemofarm Stada
Serbia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report